Logo image of RDNT

RADNET INC (RDNT) Stock Fundamental Analysis

USA - NASDAQ:RDNT - US7504911022 - Common Stock

74.45 USD
-4.05 (-5.16%)
Last: 11/12/2025, 5:48:42 PM
75 USD
+0.55 (+0.74%)
After Hours: 11/12/2025, 5:48:42 PM
Fundamental Rating

4

Overall RDNT gets a fundamental rating of 4 out of 10. We evaluated RDNT against 100 industry peers in the Health Care Providers & Services industry. RDNT has only an average score on both its financial health and profitability. RDNT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year RDNT was profitable.
In the past year RDNT had a positive cash flow from operations.
Of the past 5 years RDNT 4 years were profitable.
RDNT had a positive operating cash flow in each of the past 5 years.
RDNT Yearly Net Income VS EBIT VS OCF VS FCFRDNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

RDNT has a Return On Assets (-0.42%) which is in line with its industry peers.
The Return On Equity of RDNT (-1.60%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 2.21%, RDNT is in line with its industry, outperforming 45.00% of the companies in the same industry.
RDNT had an Average Return On Invested Capital over the past 3 years of 2.96%. This is significantly below the industry average of 9.45%.
Industry RankSector Rank
ROA -0.42%
ROE -1.6%
ROIC 2.21%
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
RDNT Yearly ROA, ROE, ROICRDNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

In the last couple of years the Profit Margin of RDNT has declined.
Looking at the Operating Margin, with a value of 4.17%, RDNT is in line with its industry, outperforming 57.00% of the companies in the same industry.
In the last couple of years the Operating Margin of RDNT has remained more or less at the same level.
RDNT has a Gross Margin (22.67%) which is in line with its industry peers.
RDNT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.17%
PM (TTM) N/A
GM 22.67%
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
RDNT Yearly Profit, Operating, Gross MarginsRDNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

4

2. Health

2.1 Basic Checks

RDNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, RDNT has about the same amount of shares outstanding.
The number of shares outstanding for RDNT has been increased compared to 5 years ago.
The debt/assets ratio for RDNT is higher compared to a year ago.
RDNT Yearly Shares OutstandingRDNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
RDNT Yearly Total Debt VS Total AssetsRDNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.17 indicates that RDNT is not a great score, but indicates only limited risk for bankruptcy at the moment.
RDNT has a Altman-Z score (2.17) which is comparable to the rest of the industry.
The Debt to FCF ratio of RDNT is 14.51, which is on the high side as it means it would take RDNT, 14.51 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of RDNT (14.51) is comparable to the rest of the industry.
RDNT has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
RDNT has a Debt to Equity ratio of 1.16. This is in the lower half of the industry: RDNT underperforms 63.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 14.51
Altman-Z 2.17
ROIC/WACC0.23
WACC9.48%
RDNT Yearly LT Debt VS Equity VS FCFRDNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

RDNT has a Current Ratio of 2.00. This indicates that RDNT is financially healthy and has no problem in meeting its short term obligations.
RDNT has a better Current ratio (2.00) than 76.00% of its industry peers.
RDNT has a Quick Ratio of 2.00. This indicates that RDNT is financially healthy and has no problem in meeting its short term obligations.
RDNT has a Quick ratio of 2.00. This is in the better half of the industry: RDNT outperforms 79.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 2
RDNT Yearly Current Assets VS Current LiabilitesRDNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The earnings per share for RDNT have decreased strongly by -37.70% in the last year.
The Earnings Per Share has been growing by 16.79% on average over the past years. This is quite good.
Looking at the last year, RDNT shows a quite strong growth in Revenue. The Revenue has grown by 13.18% in the last year.
Measured over the past years, RDNT shows a quite strong growth in Revenue. The Revenue has been growing by 9.65% on average per year.
EPS 1Y (TTM)-37.7%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%11.11%
Revenue 1Y (TTM)13.18%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%13.39%

3.2 Future

RDNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.10% yearly.
Based on estimates for the next years, RDNT will show a small growth in Revenue. The Revenue will grow by 7.93% on average per year.
EPS Next Y-34.83%
EPS Next 2Y17.9%
EPS Next 3Y20.1%
EPS Next 5YN/A
Revenue Next Year8.63%
Revenue Next 2Y8.59%
Revenue Next 3Y7.93%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
RDNT Yearly Revenue VS EstimatesRDNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
RDNT Yearly EPS VS EstimatesRDNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 195.92 indicates a quite expensive valuation of RDNT.
Based on the Price/Earnings ratio, RDNT is valued a bit more expensive than 61.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.34, RDNT is valued quite expensively.
The Price/Forward Earnings ratio is 85.01, which means the current valuation is very expensive for RDNT.
Based on the Price/Forward Earnings ratio, RDNT is valued a bit more expensive than the industry average as 61.00% of the companies are valued more cheaply.
RDNT is valuated expensively when we compare the Price/Forward Earnings ratio to 34.43, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 195.92
Fwd PE 85.01
RDNT Price Earnings VS Forward Price EarningsRDNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

RDNT's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of RDNT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 75.34
EV/EBITDA 32.84
RDNT Per share dataRDNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

RDNT's earnings are expected to grow with 20.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)11.67
EPS Next 2Y17.9%
EPS Next 3Y20.1%

0

5. Dividend

5.1 Amount

No dividends for RDNT!.
Industry RankSector Rank
Dividend Yield N/A

RADNET INC

NASDAQ:RDNT (11/12/2025, 5:48:42 PM)

After market: 75 +0.55 (+0.74%)

74.45

-4.05 (-5.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-09 2025-11-09/bmo
Earnings (Next)02-25 2026-02-25/bmo
Inst Owners93.61%
Inst Owner Change0.74%
Ins Owners12.96%
Ins Owner Change-4.92%
Market Cap5.73B
Revenue(TTM)1.83B
Net Income(TTM)-14.92M
Analysts86.15
Price Target82.18 (10.38%)
Short Float %9.94%
Short Ratio10.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-33.8%
Min EPS beat(2)-161.6%
Max EPS beat(2)93.99%
EPS beat(4)3
Avg EPS beat(4)-10.19%
Min EPS beat(4)-161.6%
Max EPS beat(4)93.99%
EPS beat(8)6
Avg EPS beat(8)171.54%
EPS beat(12)7
Avg EPS beat(12)120.14%
EPS beat(16)9
Avg EPS beat(16)-188.91%
Revenue beat(2)1
Avg Revenue beat(2)2.08%
Min Revenue beat(2)-0.11%
Max Revenue beat(2)4.27%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-0.11%
Max Revenue beat(4)4.27%
Revenue beat(8)7
Avg Revenue beat(8)1.62%
Revenue beat(12)10
Avg Revenue beat(12)2.01%
Revenue beat(16)11
Avg Revenue beat(16)0.91%
PT rev (1m)1.62%
PT rev (3m)12.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.79%
EPS NY rev (1m)6.98%
EPS NY rev (3m)73.92%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE 195.92
Fwd PE 85.01
P/S 3
P/FCF 75.34
P/OCF 21.88
P/B 6.14
P/tB 63.83
EV/EBITDA 32.84
EPS(TTM)0.38
EY0.51%
EPS(NY)0.88
Fwd EY1.18%
FCF(TTM)0.99
FCFY1.33%
OCF(TTM)3.4
OCFY4.57%
SpS24.8
BVpS12.12
TBVpS1.17
PEG (NY)N/A
PEG (5Y)11.67
Graham Number10.18
Profitability
Industry RankSector Rank
ROA -0.42%
ROE -1.6%
ROCE 2.68%
ROIC 2.21%
ROICexc 3.07%
ROICexgc 5.07%
OM 4.17%
PM (TTM) N/A
GM 22.67%
FCFM 3.98%
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
ROICexc(3y)3.61%
ROICexc(5y)3.42%
ROICexgc(3y)6.03%
ROICexgc(5y)5.63%
ROCE(3y)3.6%
ROCE(5y)3.56%
ROICexgc growth 3Y-3.51%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-4.28%
ROICexc growth 5Y-1.4%
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 14.51
Debt/EBITDA 5.61
Cap/Depr 165.16%
Cap/Sales 9.74%
Interest Coverage 0.93
Cash Conversion 136.29%
Profit Quality N/A
Current Ratio 2
Quick Ratio 2
Altman-Z 2.17
F-Score4
WACC9.48%
ROIC/WACC0.23
Cap/Depr(3y)125.7%
Cap/Depr(5y)126.7%
Cap/Sales(3y)9.85%
Cap/Sales(5y)9.84%
Profit Quality(3y)1105%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.7%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%11.11%
EPS Next Y-34.83%
EPS Next 2Y17.9%
EPS Next 3Y20.1%
EPS Next 5YN/A
Revenue 1Y (TTM)13.18%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%13.39%
Revenue Next Year8.63%
Revenue Next 2Y8.59%
Revenue Next 3Y7.93%
Revenue Next 5YN/A
EBIT growth 1Y-27.98%
EBIT growth 3Y5.38%
EBIT growth 5Y8.53%
EBIT Next Year113.89%
EBIT Next 3Y40.5%
EBIT Next 5YN/A
FCF growth 1Y93.91%
FCF growth 3Y90.52%
FCF growth 5Y8.35%
OCF growth 1Y44.3%
OCF growth 3Y15.95%
OCF growth 5Y17.44%

RADNET INC / RDNT FAQ

Can you provide the ChartMill fundamental rating for RADNET INC?

ChartMill assigns a fundamental rating of 4 / 10 to RDNT.


What is the valuation status of RADNET INC (RDNT) stock?

ChartMill assigns a valuation rating of 1 / 10 to RADNET INC (RDNT). This can be considered as Overvalued.


How profitable is RADNET INC (RDNT) stock?

RADNET INC (RDNT) has a profitability rating of 4 / 10.


What is the earnings growth outlook for RADNET INC?

The Earnings per Share (EPS) of RADNET INC (RDNT) is expected to decline by -34.83% in the next year.